Currently the price of heart stents is capped in India at INR 30,000 and all companies are selling their basic drug eluting stents at or under that price.

If a premium category and corresponding price cap is created for stents like the previous poll's finding suggests, should there be a requirement for any company listing its product in this category to have a product in the basic category on a mandatory basis?

Viewed by 8203

Related Poll

Share
Enter your email and mobile number and we will send you the instructions

Note - The email can sometime gets delivered to the spam folder, so the instruction will be send to your mobile as well

All My Circles
Invite to
(Maximum 500 email ids allowed.)